NCT03057106 2026-03-03
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Canadian Cancer Trials Group
Phase 2 Active not recruiting
Canadian Cancer Trials Group
University of Vermont
Duke University
Fudan University
University of California, San Francisco
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Chang Gung Memorial Hospital
Peking University Cancer Hospital & Institute